We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Northwest Bancshares
NWBI
$2.27B
| $413K | ﹤0.01% |
32,250
-6,640
| -17% | -$84.6K |
|
1752
Retractable Technologies
RVP
$20.1M
| $413K | ﹤0.01% |
107,890
+90,267
| +512% | +$369K |
|
|
LTRPA
1753
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $413K | ﹤0.01% |
545,935
+412,653
| +310% | +$531K |
|
1754
Gibraltar Industries
ROCK
$1.45B
| $411K | ﹤0.01% |
10,617
+4,536
| +75% | +$185K |
|
1755
Enerpac Tool Group
EPAC
$1.89B
| $410K | ﹤0.01% |
21,547
-18,757
| -47% | -$378K |
|
1756
Oil States International
OIS
$534M
| $410K | ﹤0.01% |
75,674
-30,637
| -29% | -$214K |
|
1757
HighPeak Energy
HPK
$1B
| $409K | ﹤0.01% |
+15,959
| New | +$465K |
|
1758
Noble Corp
NE
$6.95B
| $408K | ﹤0.01% |
16,103
+4,112
| +34% | +$135K |
|
1759
Identive
INVE
$61.7M
| $404K | ﹤0.01% |
+34,853
| New | +$436K |
|
|
CCF
1760
DELISTED
Chase Corporation
CCF
| $404K | ﹤0.01% |
5,193
+1,200
| +30% | +$98.3K |
|
1761
Astronics
ATRO
$3.72B
| $403K | ﹤0.01% |
+47,552
| New | +$429K |
|
1762
Albany International
AIN
$1.73B
| $398K | ﹤0.01% |
5,055
-1,377
| -21% | -$112K |
|
1763
Anterix
ATEX
$1.81B
| $398K | ﹤0.01% |
9,701
+774
| +9% | +$37.6K |
|
1764
NVE Corp
NVEC
$573M
| $393K | ﹤0.01% |
8,420
-7,041
| -46% | -$342K |
|
1765
Lakeland Financial Corp
LKFN
$1.52B
| $390K | ﹤0.01% |
5,872
+40
| +0.7% | +$2.85K |
|
|
NAGE
1766
Niagen Bioscience
NAGE
$241M
| $389K | ﹤0.01% |
232,803
-180,986
| -44% | -$354K |
|
|
VGR
1767
DELISTED
Vector Group Ltd.
VGR
| $389K | ﹤0.01% |
37,075
-3,901
| -10% | -$46.9K |
|
|
BDN
1768
Brandywine Realty Trust
BDN
$530M
| $388K | ﹤0.01% |
40,845
+24,934
| +157% | +$281K |
|
1769
Energy Recovery
ERII
$408M
| $386K | ﹤0.01% |
19,873
+580
| +3% | +$11.2K |
|
1770
Howard Hughes
HHH
$3.91B
| $386K | ﹤0.01% |
5,954
+3,783
| +174% | +$310K |
|
1771
Lumen
LUMN
$6.85B
| $383K | ﹤0.01% |
35,060
+167
| +0.5% | +$1.87K |
|
1772
Novanta
NOVT
$6.2B
| $383K | ﹤0.01% |
3,158
-640
| -17% | -$80.5K |
|
1773
Mine Safety
MSA
$7.45B
| $382K | ﹤0.01% |
3,208
+75
| +2% | +$9.32K |
|
1774
SiteOne Landscape Supply
SITE
$4.34B
| $381K | ﹤0.01% |
3,278
+1,998
| +156% | +$268K |
|
|
TGI
1775
DELISTED
Triumph Group
TGI
| $381K | ﹤0.01% |
28,662
+8,973
| +46% | +$170K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.